The Global Hyaluronic Acid API Market was valued at USD 436.90 Million in 2023 and is projected to reach USD 1,322.96 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 13.10% during the forecast period (2024–2032). This growth is being driven by booming demand for minimally invasive cosmetic procedures, rising osteoarthritis prevalence, and the shift toward sustainable fermentation-based hyaluronic acid production across pharmaceutical, cosmetic, and medical device sectors.

As the aesthetics and regenerative medicine industries transform toward biocompatible, high-purity biomaterials and sustainable manufacturing, the spotlight is on the key API suppliers who are driving innovation, scalability, and advanced applications. In this blog, we profile the Top 10 Companies in the Hyaluronic Acid API Industry—a mix of biotech innovators, fermentation specialists, and global pharma leaders shaping the future of hyaluronic acid solutions.

---

🔟 1. Seikagaku Corporation

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical-grade Hyaluronic Acid API, Cross-linked HA for orthopedics and ophthalmics

Seikagaku Corporation stands as a pioneer in hyaluronan-based therapeutics, supplying high-molecular-weight HA API for viscosupplementation and ophthalmic viscosurgical devices. The company serves major global pharma firms with strictly controlled API for joint health and eye surgeries, leveraging decades of expertise in enzymatic extraction and purification processes. Their products are integral to treatments like Synvisc, demonstrating proven efficacy in knee osteoarthritis management.

Innovation Initiatives:

• Advanced cross-linking technologies for prolonged intra-articular residence
• Strategic partnerships with orthopedic device makers
• Commitment to GMP-compliant, high-purity production scaling

Download FREE Sample Report: Hyaluronic Acid API Market – View in Detailed Research Report

---

9️⃣ 2. HTL Biotechnology

Headquarters: Reims, France
Key Offering: Non-animal Fermentation HA API, Custom molecular weights for fillers and injectables

HTL Biotechnology excels in biofermentation-derived HA API, catering to the dermal filler market with tailored viscosities and purities. Operating advanced bioreactors, the firm supplies leading aesthetic brands across Europe and beyond, emphasizing consistency critical for repeatable clinical outcomes in facial rejuvenation procedures.

Innovation Initiatives:

• Customizable HA grades for specific tissue integration
• Expansion of sterile filling capabilities
• Focus on reducing immunogenicity through purification

---

8️⃣ 3. Anika Therapeutics

Headquarters: Bedford, Massachusetts, USA
Key Offering: High molecular weight HA API, Orthobiologics and viscosupplements

Anika Therapeutics is a key U.S. player in HA API, providing pharmaceutical-grade material for its own Monovisc line and external partners. The company specializes in cross-linked formulations that enhance joint lubrication duration, supporting a growing pipeline of regenerative therapies amid rising demand for non-surgical osteoarthritis relief.

Innovation Initiatives:

• Single-injection viscosupplement development
• U.S.-based GMP manufacturing expansion
• Clinical collaborations for pain management studies

---

7️⃣ 4. Contipro a.s.

Headquarters: Dolní Dobrouč, Czech Republic
Key Offering: Fermentation-based HA API, Low to ultra-high molecular weights

Contipro leads in Europe with versatile HA API portfolios, from low MW for drug delivery to ultra-high for ophthalmics. Their bacterial fermentation platform delivers batch-consistent product, serving cosmetics, pharma, and research sectors with innovative derivatives like thiolated HA for advanced hydrogels.

Innovation Initiatives:

• Proprietary low-MW HA for skin penetration
• Europe’s largest fermentation capacity upgrades
• Sustainable, animal-free production milestones

Download FREE Sample Report: Hyaluronic Acid API Market – View in Detailed Research Report

---

6️⃣ 5. Focus Chem Biotech Ltd.

Headquarters: Jining, China
Key Offering: Bulk Fermentation HA API, Cosmetic and pharmaceutical grades

Focus Chem provides cost-effective, high-volume HA API from optimized streptococcal fermentation, targeting Asia’s booming aesthetics market. The company balances quality with scalability, supplying chains for fillers and topicals while investing in purification to meet international pharmacopeia standards.

Innovation Initiatives:

• High-yield strain engineering
• Export certifications for EU and U.S. markets
• Vertical integration for derivative production

---

5️⃣ 6. Shandong Freda Biotechnology Co., Ltd.

Headquarters: Jinan, China
Key Offering: Pharmaceutical HA API, Sodium Hyaluronate USP/EP grades

Freda Biotech is a global heavyweight in HA fermentation, producing multi-tonnage API compliant with strict regulatory specs for injectables and orals. Their facilities support diverse MW ranges, fueling growth in orthopedics and cosmetics with reliable supply amid surging demand.

Innovation Initiatives:

• Over 10,000 tons annual capacity
• EP/USP dual-certified expansions
• R&D for modified HA conjugates

---

4️⃣ 7. Kewpie Corporation

Headquarters: Tokyo, Japan
Key Offering: High-purity HA API, Food and pharma grades

Kewpie leverages food-tech expertise for clean-label HA API, extending into pharma with oral and topical applications. Known for stability in formulations, they bridge nutritionals and therapeutics, capitalizing on ingestible HA trends for joint and skin health.

Innovation Initiatives:

• Oral bioavailability enhancements
• Japan GMP food-pharma crossover
• Sustainable sourcing integrations

---

3️⃣ 8. LG Chem (Hyaltech)

Headquarters: Seoul, South Korea
Key Offering: Cross-linked HA API, Dermal fillers base material

LG Chem’s Hyaltech division dominates Korea’s aesthetics API supply, providing stabilized HA for long-lasting fillers. Their tech enables high elasticity products, aligning with K-beauty’s precision demands and global exports to premium clinics.

Innovation Initiatives:

• BDDE cross-linking patents
• Asia-Pacific capacity doubling
• Clinical data for durability claims

---

2️⃣ 9. Huayan Biotechnology Co., Ltd.

Headquarters: Jinan, China
Key Offering: Fermented HA Sodium Salt API, Multi-grade portfolios

Huayan Biotech rapidly scales HA production via advanced bioreactors, serving cosmetics giants with eye-drops to serums API. Their focus on purity and viscosity control positions them strongly in competitive Asian supply chains.

Innovation Initiatives:

• Automated fermentation monitoring
• Custom viscosity tailoring
• Global regulatory dossier support

---

1️⃣ 10. Bloomage Biotechnology Corporation

Headquarters: Jinan, Shandong, China
Key Offering: Fermentation HA API, Full spectrum MW for pharma/cosmetics

Bloomage Biotechnology reigns as the world’s largest HA API producer, with massive fermentation capacity supplying 60%+ global demand. Their pharma-grade API powers top dermal fillers like Restylane and orthopedic injectables, backed by stringent cGMP and innovation in derivatives.

Innovation Initiatives:

• 50,000+ tons/year production
• Patented ultra-pure processes
• Strategic alliances with Allergan, Galderma

Read Full Report: Hyaluronic Acid API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Hyaluronic Acid API Is Sustainable and Versatile

The hyaluronic acid API market is undergoing a dynamic shift. While traditional applications dominate, the industry is investing heavily in fermentation technologies, molecular modifications, and expanded biomedical uses like drug delivery and tissue engineering.

📈 Key Trends Shaping the Market:

• Rapid capacity expansion in Asia, Europe, and North America
• Regulatory push for animal-free, fermentation mandates
• Digital process controls for purity and yield optimization
• Pharma-cosmetic alliances for next-gen formulations

Read Full Report: Hyaluronic Acid API Market – View in Detailed Research Report

The companies listed above are not only supplying critical HA API—they’re spearheading the sustainable biotech transition in beauty and medicine.